[ad_1]
A group of scientists discovered a breakthrough treatment developed in British universities to extend the lives of women with ovarian cancer.
The drug was tested on 260 women with the disease and 135 received alternative treatment, while all underwent surgery and a certain standard of chemotherapy.
According to the New England Journal of Medicine, there is no sign of recurrence of the disease in 50% of people treated since the beginning of the test.
Professor Charlie Gullry of the University of Edinburgh, who led the British team in international experience, said that the most interesting results are that more than half of the patients treated have never had the disease, which is unprecedented and increases the chances of recovery from many of them. To weaken the cancer cells.
[ad_2]
Source link
